Bankole A Johnson
University of Virginia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bankole A Johnson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:01 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT01182766 · New Treatment for Alcohol and Nicotine DependenceUniversity of Virginia · completed · Alcohol Dependence, Nicotine Dependence · principal investigator
- Ph2NCT00223626 · Topiramate to Reduce Cocaine DependenceBankole Johnson · completed · Cocaine-Related Disorders · principal investigator
- Ph2NCT00223639 · New Medications to Treat Alcohol DependenceBankole Johnson · completed · Alcoholism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- New Pharmacotherapy for Alcohol and Co-morbid DisordersR01AA019720 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2010 to 2014 · $827,356 awarded in 2014Grant number is on one of their registry trials
- 1/2-Pharmacogenetic Treatments for AlcoholismR01AA021163 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2012 · $543,690 awarded in 2012Same name and institution; not confirmed by an ID
- Pharmacologic Treatments in Emerging AdultsR01AA010522 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 1995 to 2012 · $469,711 awarded in 2012Same name and institution; not confirmed by an ID
- Innovative Analytic Methods of Person-Centered Data and Adaptive Designs for AlcoRC1AA019274 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2009 to 2010 · $334,448 awarded in 2010Same name and institution; not confirmed by an ID
- LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE--STUDY 1M01RR000847 · NCRR · UNIVERSITY OF VIRGINIA · fiscal years 2006 to 2010 · $825,906 awarded in 2010Same name and institution; not confirmed by an ID
- Novel Pharmacotherapy for Dual DependenceR01DA019804 · NIDA · UNIVERSITY OF VIRGINIA · fiscal years 2005 to 2009 · $485,492 awarded in 2009Same name and institution; not confirmed by an ID
- Combining Medication Treatments for AlcoholismR01AA013964 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2004 to 2008 · $648,083 awarded in 2008Same name and institution; not confirmed by an ID
- Medication Development for Cocaine DependenceR01DA017296 · NIDA · UNIVERSITY OF VIRGINIA · fiscal years 2005 to 2008 · $579,640 awarded in 2008Same name and institution; not confirmed by an ID
- New Medications to Treat Alcohol DependenceR01AA014628 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2004 to 2007 · $354,065 awarded in 2007Grant number is on one of their registry trials
- LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCER01DA012191 · NIDA · UNIVERSITY OF VIRGINIA · fiscal years 1999 to 2006 · $455,145 awarded in 2006Grant number is on one of their registry trials
- COMBINED PHARMACOTHERAPIES FOR ALCOHOLISMR01AA012964 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 2001 to 2005 · $675,043 awarded in 2005Same name and institution; not confirmed by an ID
- Joint Behavior/Pharmacologic Treatment of AlcoholismU10AA011776 · NIAAA · UNIVERSITY OF VIRGINIA · fiscal years 1997 to 2004 · $41,664 awarded in 2004Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:01 UTC. The ranking covers the 200 most relevant of 81 PubMed records, and a shared surname and initials can bring in a namesake. All 81 on PubMed
- 1,302 citationsRCR 41.3
- 545 citationsRCR 16.8
- A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.Arch Gen Psychiatry · 1997419 citationsRCR 17.7
- 415 citationsRCR 13.2
- 322 citationsRCR 10.1
- A randomized trial of inhaled cyclosporine in lung-transplant recipients.N Engl J Med · 2006159 citationsRCR 4.7
- Statin use is associated with improved function and survival of lung allografts.Am J Respir Crit Care Med · 2003157 citationsRCR 4.3
- Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.Am J Psychiatry · 2011139 citationsRCR 5.0
- A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.Am J Respir Crit Care Med · 1994128 citationsRCR 5.6
- Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.Arch Gen Psychiatry · 2004124 citationsRCR 4.0